Physician profile

Michael Swete

Chicago, IL

NPI 1578067781

$96.90

in general payments reported to CMS, 2019-2025

1 company · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Rigel Pharmaceuticals, INC. $96.90 2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Swete

$96.90

in general payments reported 2019-2025

Years
2022
Top company
Rigel Pharmaceuticals, INC.

https://glasscript.com/doctor/11434987/michael-swete

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.